Table 2 System suitability: valsartan-metformin
Valsartan | Concentrations (μg.ml−1) | Area | |||
1 | 2 | 3 | Average | ||
2.00 | 3209.00 | 3235.00 | 3141.00 | 3195.00 | |
4.00 | 6597.00 | 7053.00 | 6329.00 | 6660.00 | |
8.00 | 13978.00 | 13964.00 | 12910.00 | 13617.00 | |
16.00 | 26973.00 | 26949.00 | 24405.00 | 26109.00 | |
20.00 | 32056.00 | 31936.00 | 30782.00 | 31591.00 | |
Intercept | 346.410 | 588.730 | 291.420 | 408.850 | |
Slope | 1621.00 | 1603.00 | 1522.00 | 1582.00 | |
Standard deviation | 158.186 | ||||
LOQ (μg.ml−1) | 0.999 | ||||
LOD (μg.ml−1) | 0.329 | ||||
Metformin | Concentrations (μg.ml−1) | Area | |||
1 | 2 | 3 | Average | ||
3.00 | 625.00 | 623.00 | 624.00 | 624.00 | |
15.00 | 3125.00 | 3115.00 | 3120.00 | 3120.00 | |
30.00 | 6250.00 | 6230.00 | 6240.00 | 6240.00 | |
60.00 | 11250.00 | 11214.00 | 11232.00 | 11232.00 | |
100.00 | 18750.00 | 18690.00 | 18720.00 | 18720.00 | |
Intercept | 322.900 | 321.900 | 322.400 | 322.400 | |
Slope | 184.50 | 183.90 | 184.20 | 184.200 | |
Standard deviation | 0.5 | ||||
LOQ (μg.ml−1) | 0.027 | ||||
LOD (μg.ml−1) | 0.008 | ||||